일렉트로코어 (ECOR) 주가

일렉트로코어(ECOR)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $9.97 (+0.30%), 시가총액 $0.05B, 52주 범위 $4.31 ~ $8.15.

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies f

핵심 지표

• 현재가: $9.97 (+0.30%)
• 시가총액: $0.05B
• 52주 최저~최고: $4.31 ~ $8.15
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

일렉트로코어의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

일렉트로코어 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.6

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 34.89
• 순이익률: -0.44%
• 영업이익률: -0.55%

자주 묻는 질문